Topic
Cosmetic hair growth serums
Over-the-counter serums, shampoos and tonics for thinning hair can be low-risk add-ons, but none has evidence close to minoxidil or finasteride.
Key takeaways
- No cosmetic active has evidence close to minoxidil or finasteride. The best-supported cosmetics reach fairly good evidence (adenosine) or limited evidence (caffeine and a few branded peptide blends).
- Almost all positive human data are small, short (12-24 weeks), run or paid for by the ingredient maker, and often test a blend, so no single ingredient can be credited.
- In the US, a product that claims to regrow hair is legally a drug claim, and no non-approved over-the-counter ingredient is recognised as safe and effective for it. "Cosmetic" serums therefore use vague wording such as "supports" or "stronger-looking".
- Peptide and "stem-cell" brands (Redensyl, Capixyl, Procapil, AnaGain) have limited evidence at best. Baicapil, stemoxydine and nanoxidil rest on manufacturer claims only.
- Aminexil and kopexil, the minoxidil look-alikes, have no human trials; in one rat study the aminexil product grew the least hair of three products.
- Serums make most sense as an add-on to a proven treatment, or for people who cannot or will not use drugs. They should not delay seeing a clinician for rapid or patchy loss.
The science
Cosmetic actives aim at four mechanisms: widening the follicle's blood supply or nutrient delivery (niacinamide, methyl nicotinate), signalling dermal papilla cells to prolong the growth phase (adenosine, caffeine, melatonin), blocking local androgen or inflammatory signals (many botanicals, in the lab), and "activating stem cells" (branded blends, mostly lab or maker data). Most mechanism data come from cell culture or mice, and transfer to human scalps is unproven. Delivery matters: caffeine reaches follicles within minutes from a shampoo-type formulation, but staying on the scalp long enough is a different question.
What the studies show
- A meta-analysis of 7 adenosine trials (466 people) found all positive but with very low to moderate certainty, and the pooled 0.75% lotion result at 6 months was not statistically significant. Szendzielorz 2025
- A systematic review of 9 caffeine trials (684 people) found all favoured caffeine, but certainty was medium in 3, low in 1 and very low in 5. Szendzielorz 2025
- Only 8 non-prescription agents had any investigator-blinded controlled trial in a review of 13 studies. Gupta 2025
- A 2025 review of 24 papers and technical files on branded actives such as Redensyl, Capixyl, Procapil, Baicapil and AnaGain found mostly small studies of combined formulas, often conflicted and rarely compared with standard therapy. Bikash 2025
- In a 28-day rat regrowth model of 32 animals, the Aminexil product showed the lowest hair-growth effect of the three products tested. Orasan 2016
Evidence ladder
| Evidence strength | Actives |
|---|---|
| Fairly good | adenosine (0.75% twice daily: thicker hairs; mostly company data) |
| Limited | caffeine, melatonin, rosemary oil (one comparator trial), Redensyl, Capixyl, acetyl tetrapeptide-3, Procapil, AnaGain, procyanidin B2, oral capsaicin with isoflavone, oral amla, onion juice and garlic (alopecia areata only) |
| Weak (lab or animal only) | niacinamide, methyl nicotinate, aminexil, kopexil, GHK-Cu, AHK-Cu, EGCG, red ginseng, peppermint, lavender, castor, black seed, aloe, hibiscus, bhringraj, emu oil |
| Marketing claims only | Baicapil, stemoxydine, nanoxidil, biotinoyl tripeptide-1, batana oil, rice water |
What it means by hair profile
- Early pattern thinning (any sex): serums are a low-risk complement; expect modest thickness gains, not restored density.
- Sensitive or itchy scalp: avoid essential oils and stinging "rubefacients" such as methyl nicotinate, and patch-test.
- Coarse or very curly hair: leave-in serums can add build-up. Oils may help dryness (a cosmetic effect) but not growth.
- Alopecia areata or scarring alopecia: do not self-treat with cosmetics; see a dermatologist.
Myths and facts
- Myth: "stem-cell" or "peptide" serums regrow hair like minoxidil. Fact: no head-to-head trial shows this beyond small, unblinded or placebo-free comparisons.
- Myth: natural means safe. Fact: rosemary, garlic, lavender, peppermint and other oils cause contact dermatitis.
- Myth: a company trial proves it. Fact: manufacturer-funded trials of blends cannot isolate the active, so read the design.
Bottom line
If you try a serum, pick one with adenosine or caffeine at studied concentrations, give it at least 4-6 months, photograph your hair under identical lighting, and add it to proven treatment rather than replacing it. Compare the price per month: expensive branded blends show no advantage in the evidence.
Studies 5
Szendzielorz E, Spiewak R. Adenosine as an active ingredient in topical preparations against hair loss: a systematic review and meta-analysis of published clinical trials. Biomolecules. 2025
Tested: adenosine products, mostly 0.75% lotion
Result: All 7 trials were positive but certainty was very low to moderate; pooling 3 trials of the lotion at 6 months was not significant for density (OR 1.03) or thick hairs (OR 1.4).
Read the study ↗Szendzielorz E, Spiewak R. Caffeine as an active ingredient in cosmetic preparations against hair loss: a systematic review of available clinical evidence. Healthcare (Basel). 2025
Tested: topical caffeine products
Result: All 9 trials favoured caffeine, but certainty was medium in 3, low in 1 and very low in 5; concentration was disclosed in only 2 trials.
Read the study ↗Gupta AK, Wang H, Wang T, Talukder M. Do non-prescription products help in managing androgenic alopecia? Skin Appendage Disord. 2025
Tested: non-prescription monotherapies
Result: Only 8 non-prescription agents, including rosemary oil, had any investigator-blinded controlled trial.
Read the study ↗Bikash C. Topical alternatives for hair loss: beyond the conventional. Int J Trichology. 2025
Tested: Redensyl, Capixyl, Procapil, Baicapil, AnaGain and similar actives
Result: Evidence is mostly small studies of combined formulas, often conflicted and rarely compared with standard therapy.
Read the study ↗Orasan MS et al. Topical products for human hair regeneration: a comparative study on an animal model. Ann Dermatol. 2016
Tested: 2% minoxidil vs Aminexil product vs Kerium product vs sham
Result: Minoxidil induced regrowth; the Aminexil product showed the lowest hair-growth effect of the three products.
Read the study ↗Related
- Adenosine (topical)Adenosine, a natural signalling molecule, is the cosmetic hair active with the cleanest small placebo-controlled trials, mainly making thin hairs thicker.
- Caffeine (topical)Caffeine in shampoos and leave-on liquids clearly stimulates hair follicles in the lab, but the human trials are small, mostly industry-run and mostly on blends.
- RedensylRedensyl is a branded cosmetic blend marketed to wake follicle stem cells, with one small vehicle-controlled trial in a blend and several maker-linked open-label studies.
- CapixylCapixyl is a branded blend of a peptide and a red clover isoflavone; one tiny trial of a similar blend matched 3% minoxidil, with no placebo arm.
- ProcapilProcapil is a branded trio of a biotin-linked peptide, apigenin and oleanolic acid sold as a hair-anchoring active, with small studies that are mostly add-ons to other treatments.
- AnaGainAnaGain is a pea sprout extract with a small maker-run study and mouse data, plausible and low risk but without an independent controlled trial.
- BaicapilBaicapil is a supplier-branded plant-extract active found in hair serums, with no published human trial behind it.
- StemoxydineStemoxydine is a cosmetic compound from L'Oréal pitched as mimicking the low-oxygen niche of follicle stem cells, with no peer-reviewed trial.
- NanoxidilNanoxidil is a marketing name for a cosmetic "minoxidil alternative" with no chemical definition and no peer-reviewed study that could be found.
- AminexilAminexil is a minoxidil-like cosmetic sold as an anti-shedding ampoule, with no human trial and a rat study that found it the weakest of the products tested.
- KopexilKopexil is a minoxidil look-alike sold in cosmetic serums; a 2025 mouse study found it beat minoxidil, but there is no published human trial.
- MinoxidilThe most widely used hair-growth treatment, available as a cheap over-the-counter lotion or foam and as a prescription tablet, with a mechanism that is still only partly understood.
- FinasterideA prescription pill (and in some countries a scalp spray) that lowers DHT and is the best-proven drug for stopping male pattern hair loss.
- Natural remedies for hair growthNo natural remedy has strong evidence for growing hair, and the real value of most oils and plant extracts is cosmetic.